Key result
Potassium supplements, NSAIDs, and amoxicillin/clavulanic acid linked to ~104% higher HF hospitalization and shock risk.
Why the study?
Heart failure is among the leading causes of hospitalization in Europe, prompting an evaluation of potential precipitating medication factors for heart failure and shock hospitalizations.
Does short-term prescription of oral potassium supplements, NSAIDs, or amoxicillin/clavulanic acid increase the risk of hospitalization for heart failure and shock in adults?
Observational (n=2,185)
Does short-term prescription of oral potassium supplements, NSAIDs, or amoxicillin/clavulanic acid increase the risk of hospitalization for heart failure and shock in adults?
Short-term prescription of potassium supplements, NSAIDs, and amoxicillin/clavulanic acid is associated with an increased risk of hospitalization for heart failure and shock, highlighting the need for careful monitoring when these drugs are prescribed to vulnerable patients.
PURPOSE: Heart failure is among the leading causes for hospitalization in Europe. In this study, we evaluate potential precipitating factors for hospitalization for heart failure and shock. METHODS: Using Swiss claims data (2014-2015), we evaluated the association between hospitalization for heart failure and shock, and prescription of oral potassium supplements, non-steroidal anti-inflammatory drugs (NSAIDs), and amoxicillin/clavulanic acid. We conducted case-crossover analyses, where exposure was compared for the hazard period and the primary control period (e.g., 1-30 days before hospitalization vs. 31-60 days, respectively). Conditional logistic regression was applied and subsequently adjusted for addressing potential confounding by disease progression. Sensitivity analyses were conducted and stratification for co-medication was performed. RESULTS: We identified 2185 patients hospitalized with heart failure or shock. Prescription of potassium supplements, NSAIDs, and amoxicillin/clavulanic acid was significantly associated with an increased risk for hospitalization for heart failure and shock with crude odds ratios (OR) of 2.04 for potassium (95% CI 1.24-3.36, p = 0.005, 30 days), OR 1.8 for NSAIDs (95% CI 1.39-2.33, p < 0.0001, 30 days), and OR 3.25 for amoxicillin/clavulanic acid (95% CI 2.06-5.14, p < 0.0001, 15 days), respectively. Adjustment attenuated odds ratios, while the significant positive association remained (potassium OR 1.70 (95% CI 1.01-2.86, p = 0.046), NSAIDs OR 1.50 (95% CI 1.14-1.97, p = 0.003), and amoxicillin/clavulanic acid OR 2.26 (95% CI 1.41-3.62, p = 0.001). CONCLUSION: Prescription of potassium supplements, NSAIDs, and amoxicillin/clavulanic acid is associated with increased risk for hospitalization. Underlying conditions such as pain, electrolyte imbalances, and infections are likely contributing risk factors. Physicians may use this knowledge to better identify patients at risk and adapt patient management.
No takes yet. Share an insight, caveat, or question.
Jödicke et al. (2020) conducted an observational in Heart failure and shock (n=2,185). Potassium supplements, NSAIDs, and amoxicillin/clavulanic acid vs. Control period (e.g., 31-60 days before hospitalization) was evaluated on Hospitalization for heart failure and shock (potassium supplements exposure) (OR 2.04, 95% CI 1.24-3.36, p=0.005). Prescription of potassium supplements, NSAIDs, and amoxicillin/clavulanic acid significantly increased the risk of hospitalization for heart failure and shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: